Leszek Królicki

4.6k total citations · 1 hit paper
186 papers, 3.0k citations indexed

About

Leszek Królicki is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Epidemiology. According to data from OpenAlex, Leszek Królicki has authored 186 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Radiology, Nuclear Medicine and Imaging, 49 papers in Neurology and 38 papers in Epidemiology. Recurrent topics in Leszek Królicki's work include Radiopharmaceutical Chemistry and Applications (30 papers), Neuroendocrine Tumor Research Advances (28 papers) and Medical Imaging Techniques and Applications (27 papers). Leszek Królicki is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (30 papers), Neuroendocrine Tumor Research Advances (28 papers) and Medical Imaging Techniques and Applications (27 papers). Leszek Królicki collaborates with scholars based in Poland, Germany and Switzerland. Leszek Królicki's co-authors include Jolanta Kunikowska, Dariusz Pawlak, Aliyah Morgenstern, Frank Bruchertseifer, Andrzej Friedman, Christos Apostolidis, Renata Mikołajczak, Anna Potulska‐Chromik, Małgorzata Kobylecka and Mike Sathekge and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Leszek Królicki

177 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

2018 253 citations Leszek Królicki et al. profile →

Peers

Countries citing papers authored by Leszek Królicki

Since Specialization

Citations

This map shows the geographic impact of Leszek Królicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leszek Królicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leszek Królicki more than expected).

Fields of papers citing papers by Leszek Królicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leszek Królicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leszek Królicki. The network helps show where Leszek Królicki may publish in the future.

Co-authorship network of co-authors of Leszek Królicki

This figure shows the co-authorship network connecting the top 25 collaborators of Leszek Królicki. A scholar is included among the top collaborators of Leszek Królicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leszek Królicki. Leszek Królicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Motor cortex activation mediates associations between striatal dopamine depletion and manual dexterity in Parkinson's disease 2024 ·Parkinsonism & Related Disorders ·(unknown), (unknown), Leszek Królicki, Małgorzata Chalimoniuk, Katarzyna Markowska, Sławomir Budrewićz, Magdalena Koszewicz, Łukasz Szumowski, Jarosław Marusiak	2
2	Slowing of EEG waves correlates with striatal [ ¹⁸ F]fluorodopa PET/CT uptake and executive dysfunction in Parkinson's disease 2023 ·European Journal of Neuroscience ·(unknown), (unknown), Leszek Królicki, (unknown), Małgorzata Chalimoniuk, Katarzyna Kisiel‐Sajewicz, Jarosław Marusiak	3
3	Inflammation in multiple system atrophy 2023 ·Frontiers in Immunology ·(unknown), Natalia Madetko‐Alster, Piotr Alster, Leszek Królicki, Urszula Fiszer, Dariusz Koziorowski	20
4	The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy 2023 ·Diagnostics ·(unknown), Piotr Alster, Natalia Madetko‐Alster, (unknown), Leszek Królicki, Bartosz Migda	1
5	The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) 2022 ·Diagnostics ·Piotr Alster, Natalia Madetko‐Alster, Bartosz Migda, (unknown), Dariusz Koziorowski, Leszek Królicki	3
6	The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes 2022 ·Diagnostics ·Piotr Alster, Natalia Madetko‐Alster, Bartosz Migda, (unknown), (unknown), Leszek Królicki, Andrzej Friedman	1
7	Is MRPI 2.0 More Useful than MRPI and M/P Ratio in Differential Diagnosis of PSP-P with Other Atypical Parkinsonisms? 2022 ·Journal of Clinical Medicine ·Natalia Madetko‐Alster, Piotr Alster, (unknown), Bartosz Migda, (unknown), Dariusz Koziorowski, Leszek Królicki	10
8	The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant 2022 ·Diagnostics ·Natalia Madetko‐Alster, Piotr Alster, Bartosz Migda, (unknown), Dariusz Koziorowski, Leszek Królicki	3
9	The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT) 2022 ·Diagnostics ·Piotr Alster, (unknown), Bartosz Migda, (unknown), Natalia Madetko‐Alster, (unknown), (unknown), Dariusz Koziorowski, Leszek Królicki, Andrzej Friedman	15
10	The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET 2021 ·International Journal of Endocrinology ·Anna Zemczak, Paweł Gut, Dariusz Pawlak, (unknown), Leszek Królicki, Beata Kos‐Kudła, Marek Ruchała, Grzegorz Kamiński, Jolanta Kunikowska	12
11	Is low radioiodine uptake a contraindication to radioiodine therapy in patients with benign thyroid disease? 2021 ·Advances in Clinical and Experimental Medicine ·(unknown), Agata Czarnywojtek, Nadia Sawicka‐Gutaj, Kosma Woliński, Iwona Krela‐Kaźmierczak, Małgorzata Zgorzalewicz-Stachowiak, Izabela Miechowicz, Paweł Gut, Ewa Florek, Karolina Skonieczna‐Żydecka, Marek Ruchała, Leszek Królicki	0
12	Recommendations on the application of positron emission tomography in oncology 2015 ·Oncology in Clinical Practice ·Maciej Krzakowski, Piotr Rutkowski, Jacek Jassem, Renata Zaucha, (unknown), (unknown), Barbara Jarząb, Wojciech Zegarski, Bogdan Małkowski, Andrzej Kawecki, Witold Rzyman, Andrea d’Amico, (unknown), Wojciech Polkowski, (unknown), Leszek Królicki	1
13	Nephrotoxicity after PRRT - still a serious clinical problem? Renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATATE and 90Y/177Lu-DOTATATE. 2013 ·PubMed ·Jolanta Kunikowska, Leszek Królicki, Anna Sowa‐Staszczak, Dariusz Pawlak, Alicja Hubalewska‐Dydejczyk, Renata Mikołajczak	12
14	Clinical immunology Immunoregulatory disorders in irritable bowel syndrome 2011 ·Central European Journal of Immunology ·Wanda Stankiewicz, (unknown), (unknown), Jolanta Białkowska, (unknown), (unknown), Leszek Królicki, J Muszyński	2
15	Diagnostic imaging of neuroendocrine tumours 2006 ·Oncology in Clinical Practice ·Jarosław B. Ćwikła, Leszek Królicki, John Buscombe, Jerzy Walecki	1
16	Przebieg leczenia nowotworów typu NET pochodnymi somatostatyny znakowanymi radioizotopowo 2005 ·Endokrynologia Polska ·Jolanta Kunikowska, Leszek Królicki, Jarosław B. Ćwikła, Renata Mikołajczak, Dariusz Pawlak, (unknown), (unknown), (unknown), (unknown), Małgorzata Kobylecka, (unknown), Katarzyna Życińska, Kazimierz Wardyn	0
17	Znaczenie metod neuroobrazowania w diagnostyce padaczek 2005 ·Via Medica Journals ·(unknown), Leszek Królicki	1
18	ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Ultrasonography, magnetic resonance imaging and conventional radiography of bone erosions in rheumatoid arthritis – a comparative study 2005 ·Reumatologia/Rheumatology ·(unknown), (unknown), (unknown), (unknown), Witold Tłustochowicz, (unknown), Leszek Królicki, W Jakubowski	3
19	Persisted/recurrent hyperparathyroidism associated with development of multi-drug resistance phenotype and proliferation of parathyroid transplants. 2004 ·International Journal of Molecular Medicine ·Tomasz Grzela, Witold Chudziński, Maciej Łazarczyk, Justyna Niderla, Piotr Dziunycz, Łukasz Milewski, Robert Brawura-Biskupski-Samaha, Małgorzata Kobylecka, (unknown), (unknown), Barbara Górnicka, (unknown), (unknown), Leszek Królicki	5
20	New therapeutic options of carcinoid syndrome metastatic to the liver. 2001 ·PubMed ·(unknown), (unknown), (unknown), K Ostrowski, Marcin Krawczyk, Leszek Królicki, M. Caplin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact